Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_038A75FF6EF1
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis.
Journal
Arthritis and Rheumatism
Author(s)
Ruperto N., Lovell D.J., Quartier P., Paz E., Rubio-Pérez N., Silva C.A., Abud-Mendoza C., Burgos-Vargas R., Gerloni V., Melo-Gomes J.A., Saad-Magalhães C., Chavez-Corrales J., Huemer C., Kivitz A., Blanco F.J., Foeldvari I., Hofer M., Horneff G., Huppertz H.I., Job-Deslandre C., Loy A., Minden K., Punaro M., Nunez A.F., Sigal L.H., Block A.J., Nys M., Martini A., Giannini E.H., Paediatric Rheumatology International Trials Organization
Working group(s)
the Pediatric Rheumatology Collaborative Study Group
ISSN
1529-0131[electronic], 0004-3591[linking]
Publication state
Published
Issued date
2010
Volume
62
Number
6
Pages
1792-1802
Language
english
Notes
Publication types: Clinical Trial, Phase III ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Keywords
Adolescent, Antirheumatic Agents/adverse effects, Antirheumatic Agents/therapeutic use, Arthritis, Juvenile Rheumatoid/drug therapy, Child, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Humans, Immunoconjugates/adverse effects, Immunoconjugates/therapeutic use, Methotrexate/therapeutic use, Severity of Illness Index, Treatment Outcome, Tumor Necrosis Factor-alpha/antagonists & inhibitors
OAI-PMH
oai:serval.unil.ch:BIB_038A75FF6EF1
DOI
10.1002/art.27431
Pubmed
20191582
Web of science
000279432500031
Create date
31/01/2011 17:44
Last modification date
20/08/2019 13:25
Usage data